Wanbury Share Price
Start SIP in Wanbury
Start SIPWanbury Performance
Day Range
- Low 243
- High 259
52 Week Range
- Low 60
- High 270
- Open Price252
- Previous Close251
- Volume65418
Wanbury Investment Rating
-
Master Rating:
-
Wanbury has an operating revenue of Rs. 560.47 Cr. on a trailing 12-month basis. An annual revenue growth of 16% is outstanding, Pre-tax margin of 10% is healthy, ROE of 200% is exceptional. The company has a high debt to equity of 293%, which can be a reason to worry. The stock from a technical standpoint is comfortably placed above its key moving averages, around 21% and 56% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 24 which is a POOR score indicating inconsistency in earnings, a RS Rating of 93 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 59 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 131 | 139 | 145 | 144 | 146 | 133 |
| Operating Expenses Qtr Cr | 120 | 121 | 124 | 127 | 133 | 119 |
| Operating Profit Qtr Cr | 11 | 18 | 21 | 17 | 13 | 14 |
| Depreciation Qtr Cr | 3 | 3 | 3 | 3 | 3 | 3 |
| Interest Qtr Cr | 8 | 7 | 8 | 8 | 6 | 8 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | 1 | 8 | 10 | 7 | 5 | 1 |
Wanbury Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹233.60
- 50 Day
- ₹212.14
- 100 Day
- ₹190.56
- 200 Day
- ₹162.72
- 20 Day
- ₹233.71
- 50 Day
- ₹209.32
- 100 Day
- ₹180.74
- 200 Day
- ₹161.83
Wanbury Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 262.33 |
| Second Resistance | 268.46 |
| Third Resistance | 278.13 |
| RSI | 66.81 |
| MFI | 39.37 |
| MACD Single Line | 11.68 |
| MACD | 13.09 |
| Support | |
|---|---|
| First Support | 246.53 |
| Second Support | 236.86 |
| Third Supoort | 230.73 |
Wanbury Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 81,151 | 8,115,100 | 100 |
| Week | 116,047 | 11,604,740 | 100 |
| 1 Month | 202,560 | 15,060,346 | 74.35 |
| 6 Month | 191,150 | 13,797,215 | 72.18 |
Wanbury Result Highlights
Wanbury Synopsis
NSE-Medical-Generic Drugs
Wanbury is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 499.65 Cr. and Equity Capital is Rs. 32.71 Cr. for the Year ended 31/03/2023. Wanbury Ltd. is a Public Limited Listed company incorporated on 11/08/1988 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L51900MH1988PLC048455 and registration number is 048455.| Market Cap | 839 |
| Sales | 560 |
| Shares in Float | 1.96 |
| No of funds | 6 |
| Yield |
| Book Value | 30.03 |
| U/D Vol ratio | 1.6 |
| LTDebt / Equity | 293 |
| Alpha | 0.5 |
| Beta | 0.95 |
Wanbury Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 39.79% | 39.79% | 39.79% | 39.8% |
| Mutual Funds | ||||
| Foreign Portfolio Investors | 0.22% | 0.18% | ||
| Financial Institutions/ Banks | ||||
| Individual Investors | 41.41% | 41.81% | 39.09% | 39.53% |
| Others | 18.58% | 18.22% | 21.12% | 20.67% |
Wanbury Management
| Name | Designation |
|---|---|
| Mr. K Chandran | Vice Chairman & Whole Time Dir |
| Mr. N K Puri | Ind. Non-Executive Director |
| Ms. Pallavi P Shedge | Ind. Non-Executive Director |
Wanbury Forecast
Price Estimates
Wanbury Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-12 | Quarterly Results | |
| 2024-05-16 | Audited Results | |
| 2024-01-24 | Quarterly Results | |
| 2023-10-20 | Quarterly Results & Preferential issue | Inter-alia, to consider and evaluate proposals for raising of funds by way of a preferential issue/allotment and private placement to promoters/promoter group of the Company. |
| 2023-08-11 | Quarterly Results |
Wanbury FAQs
What is Share Price of Wanbury ?
Wanbury share price is ₹256 As on 18 September, 2024 | 02:23
What is the Market Cap of Wanbury ?
The Market Cap of Wanbury is ₹838.9 Cr As on 18 September, 2024 | 02:23
What is the P/E ratio of Wanbury ?
The P/E ratio of Wanbury is 16 As on 18 September, 2024 | 02:23
What is the PB ratio of Wanbury ?
The PB ratio of Wanbury is 30 As on 18 September, 2024 | 02:23